Name: Omni Super Global. Fundamental
Brand: smallcase
SKU: OMNMO_0026
Price: 1000000 INR

A Global Equity Specialist founded by IITians with a combined experience of more than 40 yrs. OmniScience uses Scientific Investing to create SuperNormal Portfolios to ‘Enhance Safety, Enhance Growth, Enhance Returns’

Nifty 100 Index

Omni Super Global

Omni Super Global. Fundamental

Ashwini

Leaders of Global Equities with the Best of India Inc.

Primarily the companies which have a market capitalization of more than 1000 crore and are traded on the National Stock Exchange of India are included in the universe. This universe also includes all Global ETFs.

The portfolio is based on the Scientific Investing framework which sifts through the defined portfolio universe and weeds out capital destroying equities based on&nbsp;an&nbsp;analysis of the balance sheet, cashflows, growth and valuation. It curates a portfolio of capital multiplying companies with SuperNormal Profitability (economic alpha) arising from persistent competitive advantages and growth opportunities (growth alpha). A superior valuation toolkit further capitalizes on Mr. Market’s behavioral errors and selects companies available at SuperNormal Prices (value alpha),&nbsp;i.e.&nbsp;below their intrinsic values.

The Scientific Investing Framework helps building a portfolio of SuperNormal Companies @ SuperNormal Prices exhibiting the following attributes:<ul><li>Fundamental Balance sheet Strength</li><li>Persistent Competitive Advantage</li><li>Large Growth Opportunity</li><li>High Earnings or&nbsp;Cash Flow&nbsp;Yield</li><li>High Compounding&nbsp;or Growth&nbsp;rates</li><li>High Cash&nbsp;or Low Debt&nbsp;to MarketCap</li></ul>&nbsp;The Scientific Investing approach helps in reducing exposure to 3 types of fundamentally risky&nbsp;companies, viz., Capital Destroyers, i.e. companies with weak business operations and weak balance sheets, Capital Eroders, i.e. companies with&nbsp;low or&nbsp;no competitive advantages resulting in inefficient use of shareholder capital and Capital Imploders, i.e. companies which are significantly overvalued making them vulnerable to either company/sector/market/economy specific shocks. The framework helps to identify Capital Multipliers, which are companies with strong,&nbsp;typically,&nbsp;cash-rich balance sheets powering business operations with persistent competitive advantages and resources to capitalize on the potential high-growth opportunities that the company is exposed to.&nbsp;Also, these companies should be available at a significant discount to their intrinsic value.

The portfolio allocation&nbsp;can depend&nbsp;on the degree of undervaluation. Securities that have higher discount to intrinsic value&nbsp;can be&nbsp;given higher weightage and vice versa. Securities with similar discount to intrinsic value are, typically, given roughly equal weightages.

This smallcase will be rebalanced on an as-needed basis

Omni Super Global. Fundamental

Omni Super Global. Fundamental

Overview

Stocks & ETFs